Back

Implementing a novel clinical scientist led cardio-oncology service in everyday clinical practice.

25 May 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 2 - Cardiovascular Disease in Special Populations Cardio-Oncology HFA Premium Access Heart Failure 2019

About the speaker

Photo
Miss Jane Draper

St Thomas', London (United Kingdom of Great Britain & Northern Ireland)

13 More presentations in this session

Presentation thumbnail
Trastuzumab associated cardiotoxicity in breast cancer patients: a report after 4 years of follow up at a specialized centre
Doctor M. Tettamanti (Buenos Aires, AR)
Abstract Slides
Presentation thumbnail
Body mass index and resting heart rate in unselected prospectively enrolled cancer patients
Doctor S. Hadzibegovic (Berlin, DE)
Abstract
Presentation thumbnail
Echocardiographic assessment in cancer patients
Doctor A. Lena (Berlin, DE)
Abstract
Presentation thumbnail
Troponin T, NT-proBNP and CRP: prognostic markers of mortality in cancer patients
Ms L. Lueck (Berlin, DE)
Abstract
Presentation thumbnail
Biomarkers and imaging modalities for the diagnosis of cardiotoxicity after chemotherapy; data from the greek multicenter cardio-oncology registry
Doctor A. Ntalianis (Athens, GR)
Abstract

Access the full session

Session thumbnail
Poster Session 2 - Cardiovascular Disease in Special Populations

The Event

Event poster

Heart Failure 2019

25 May - 28 May 2019

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources